Showing results (1031-1040 of 2,233) with videos related to
Sort By:
Pageof 224
Diabetes, Obesity & Metabolism|April 26, 2008
Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) studyF Alvarez Guisasola, P Mavros, G Nocea, et al.Indian Journal of Endocrinology and Metabolism|June 20, 2014
Risk of developing adulthood obesity among females born with low birth weight: Results from a non-concurrent study from rural Southern IndiaArup Chakraborty, P S Rakesh, V Kumaran, et al.Journal of Occupational and Environmental Hygiene|January 2, 2025
Hazardous exposures and engineering controls in the landscaping services industryBarbara M Alexander, Pamela S Graydon, Mirle Pena, et al.Cureus|July 24, 2023
Multivariate Modeling of Student Performance on NBME Subject ExamsSeth M Alexander, Christina L Shenvi, Kimberley R Nichols, et al.Aviation, Space, and Environmental Medicine|March 1, 1976
Head and neck cooling by air, water, or air plus water in hyperthermiaA T Kissen, W C Summers, W J Buehring, et al.Biochemistry|June 26, 2002
Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking studyDror Yahalom, Angela Wittelsberger, Dale F Mierke, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 20, 2002
Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric studyShobna Vedi, Mary Ninkovic, Nigel J Garrahan, et al.Brain Research|August 21, 1992
Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeysG M Alexander, R J Schwartzman, L Brainard, et al.Journal of Bacteriology|April 25, 2018
d-Alanyl-d-Alanine Ligase as a Broad-Host-Range Counterselection Marker in Vancomycin-Resistant Lactic Acid BacteriaShenwei Zhang, Jee-Hwan Oh, Laura M Alexander, et al.Cancer Gene Therapy|July 6, 2000
Mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumorsW Walther, U Stein, I Fichtner, et al.Pageof 224